SUO 2019 Prostate Cancer

Viewing 1-20 of 30 articles

SUO 2019: Bipolar AR Therapy

SUO 2019: Bipolar Androgen Therapy for Men with Castration Resistant Prostate Cancer

SUO 2019: Optimal Management of Metastatic Castration Sensitive Prostate Cancer

SUO 2019: PARP Inhibitors for Prostate Cancer

SUO 2019: Implementation of Standard Opioid Prescribing Schedules Following Urologic Surgeries Reduces Opioid Prescriptions Without Change in Patient Reported Outcomes

SUO 2019: Poly ADP Ribose Polymerase (PARP) Inhibitors for Prostate Cancer

SUO 2019: Transperineal Versus Transrectal Ultrasound-Guided Systematic Biopsy: Understanding the True Costs Utilizing Time-Driven Activity-Based Costing

SUO 2019: Evaluation of Biomarkers 4K Score, SelectMDx and ExoDx™, PSAD, TRUS and MRI for the Detection of High-Grade Prostate Cancer

SUO 2019: Characterization of 68GA-PSMA and 18F-Fluciclovine (Axumin®) Transporter Gene Expression in Localized Prostate Cancer

SUO 2019: My Active Surveillance Trajectory: A Literary Bibliography - Laurence Klotz

SUO 2019: Radiotherapy after Radical Prostatectomy: Effect of Timing of Post-Prostatectomy Radiation on Functional Outcomes

SUO 2019: How to Improve Uro-Oncological Surgery with Intraoperative Real-Time Multisensory Technology

SUO 2019: Heterogeneity in Policy Effect: Changes in Prostate Cancer Screening Associated with ACO Participation

SUO 2019: 2019 Richard D. Williams, MD Prostate Cancer Research Excellence Award Lecture: Prostate Cancer Screening

SUO 2019: Genomic Umbrella Neoadjuvant Study and other Biomarker Trials

SUO 2019: An Update on CALGB 90203, Radical Prostatectomy with or without Neoadjuvant Chemohormonal Therapy in Men with Clinically Localized, High-Risk Prostate Cancer, The PUNCH Study

SUO 2019: Evolving Role of Genomic Biomarkers in Localized Prostate Cancer

SUO 2019: What Can We Learn from the Breast Experience?

SUO 2019: Novel Hormone Therapies + Androgen Receptor Pathway Inhibition

SUO 2019: Organ Preservation in Urologic Cancers - Prostate Cancer

1
2